Troy Edward Wilson Insider Profile
11 Followers
Troy Edward Wilson, President & CEO, Director at Kura Oncology, holds 1.21M shares in Kura Oncology (Ticker: KURA), holds 60.30K shares in Puma Biotechnology (Ticker: PBYI), holds 0.00 shares in Avidity Biosciences (Ticker: RNAM). Most recently, Troy Edward Wilson Bought ― shares of Kura Oncology on Aug 24, 2026 for an estimated value of $1.24M.
Troy Edward Wilson Kura Oncology (KURA)President & CEO, Director
Kura Oncology (KURA)
President & CEO, Director
Ranked #21,353 out of 109,030 Corporate Insiders
Profitable Transactions
4 out of 7 Profitable Transactions
Average Return
+11.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Troy Edward Wilson holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jun 11, 2021 - Jun 11, 2022
Return:+77.10%
The most profitable trade made by Troy Edward Wilson
Troy Edward Wilson's Trading History
Kura Oncology
Aug 24, 2026
President & CEO, Director
Informative Buy
1.24M
$13.83M
Avidity Biosciences
Feb 27, 2026
―
Uninformative Sell
―
$0.00
Puma Biotechnology
Jun 15, 2026
Director
Uninformative Buy
―
$549.94K
Zosano Pharma
―
―
―
―
List of latest transactions for each holding click on a transaction to see Troy Edward Wilson's performance on stock
You May Also Like
Troy Edward Wilson insider profile FAQ
What is the percentage of profitable transactions made by Troy Edward Wilson?
The percentage of profitable transactions made by Troy Edward Wilson is 57%.
What is the average return per transaction made by Troy Edward Wilson?
The average return per transaction made by Troy Edward Wilson is 11.60%.
What stocks does Troy Edward Wilson hold?
Troy Edward Wilson holds: KURA, RNAM, PBYI, ZSANQ stocks.
What was Troy Edward Wilson’s latest transaction?
Troy Edward Wilson latest transaction was an Informative Buy of $1.24M.
What was Troy Edward Wilson's most profitable transaction?
Troy Edward Wilson’s most profitable transaction was an Informative Sell of PBYI stock on June 11, 2021. The return on the trade was 77.10%.
What is Troy Edward Wilson's role in Kura Oncology?
Troy Edward Wilson's role in Kura Oncology is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.